YOUR BUSINESS AUTHORITY
Springfield, MO
San Francisco-based immunology company Vir Biotechnology Inc. (Nasdaq: VIR) is expanding to St. Louis.
The biotechnology firm is opening an office and innovation lab in space previously occupied by Washington University.
Vir has several drug candidates for infectious diseases, including COVID-19.
Read more from the St. Louis Business Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach